Version May 2024
| FDA approved indications |
| Psoriasis* |
| Vitiligo¶ |
| Off label dermatologic uses |
| Neoplastic |
| Mycosis fungoides/Sezary syndrome |
| Histiocytosis X (Langerhans cell histiocytosis) |
| Papulosquamous/dermatitis |
| Atopic dermatitis |
| Seborrheic dermatitis |
| Chronic hand dermatitis |
| Palmoplantar pustulosis |
| Lichen planus |
| Parapsoriasis |
| Pityriasis lichenoides |
| Lymphomatoid papulosis |
| Photosensitivity dermatoses |
| Polymorphous light eruption |
| Erythropoietic protoporphyria |
| Solar urticaria |
| Chronic actinic dermatitis |
| Other pruritic dermatoses |
| Dermographism |
| Aquagenic urticaria/pruritus |
| Chronic urticaria |
| Polycythemia vera |
| Idiopathic pruritus |
| Urticaria pigmentosa |
| Prurigo nodularis |
| Other immunologic dermatoses |
| Alopecia areata |
| Graft-versus-host disease |
| Morphea |
| Linear scleroderma |
| Miscellaneous dermatoses |
| Transient acantholytic dermatosis (Grover's disease) |
| Pigmented purpuric dermatoses |
| Ichthyosis linearis circumflexa |
| Scleromyxedema |
| Generalized granuloma annulare |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
